Clinical Trials Browser

Phase 1 × Interventional × vadastuximab talirine × Clear all

NCT02326584 2018-05-09

A Safety Study of SGN-CD33A in Combination With Standard-of-care in Patients With AML

Phase 1 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT01902329 2018-01-05

A Safety Study of SGN-CD33A in AML Patients

Phase 1 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute, Leukemia, Promyelocytic, Acute